Sort by 'shares'
Nanotech as Prevention by Nanotronics Imaging & MetaMed
In this show we discuss Nanotechnology as Prevention with Dr. Mathew Putman, CEO, Nanotronics Imaging, Andrew Rettek from MetaMed, and Dr. Georges Sylvestre from Weill Cornell.
Minimal Residual Disease with Dr. Guido Tricot
What is the difference, if there is one, between MRDzero and MRD negative? Do these definitions vary from institution to institution or are they standardized? The ultimate goal of treatment is to achieve MRDzero. If a patient does not achieve…
Male Infertility and Sexual Health
Male infertility is an issue that is not discussed openly, though it is one of the contributing factors in couples who fail to conceive. However, rapid advances in male reproduction research allows us to diagnose and treat male infertility way…
Beating Leukemia with Groundbreaking CAR-T Cell Therapy
Dr. Stephan A. Grupp made history when he treated the first child with CAR T cell therapy, Emily Whitehead, who is now more than five years cancer-free. In CAR-T cell therapy, a patient's own genetically altered immune cells fight cancer.…
Off-the-shelf Immune Drug for Aggressive Multiple Myeloma: Teclistamab
U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for teclistamab in the treatment of relapsed or refractory multiple myeloma. This follows a PRIME (PRIority MEdicines) designation from the European Medicines Agency (EMA) received earlier this year. …